GPPL RIZATRIPTAN rizatriptan (as benzoate) 5 mg orally disintegrating tablets blisters

Land: Australia

Språk: engelsk

Kilde: Department of Health (Therapeutic Goods Administration)

Aktiv ingrediens:

rizatriptan benzoate, Quantity: 7.265 mg (Equivalent: rizatriptan, Qty 5 mg)

Tilgjengelig fra:

Arrotex Pharmaceuticals Pty Ltd

INN (International Name):

rizatriptan benzoate

Legemiddelform:

Tablet, orally disintegrating

Sammensetning:

Excipient Ingredients: hypromellose; mannitol; silicon dioxide; crospovidone; acesulfame potassium; colloidal anhydrous silica; sodium stearylfumarate; ethylcellulose; Flavour

Administreringsrute:

Sublingual

Enheter i pakken:

6, 2, 3

Resept typen:

(S4) Prescription Only Medicine

Indikasjoner:

for acute treatment of migraine attacks with or without aura.

Produkt oppsummering:

Visual Identification: White to off-white, round, flat face beveled edge tablets, debossed with 'C6' on one side and 'C' on the other side, having a characteristic flavour; Container Type: Blister Pack; Container Material: Other composite material; Container Life Time: 24 Months; Container Temperature: Store below 25 degrees Celsius; Container Closure: Child resistant closure

Autorisasjon status:

Licence status A

Autorisasjon dato:

2015-03-20